These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 14512536)

  • 1. Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responses.
    Sarobe P; Lasarte JJ; Zabaleta A; Arribillaga L; Arina A; Melero I; Borrás-Cuesta F; Prieto J
    J Virol; 2003 Oct; 77(20):10862-71. PubMed ID: 14512536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cells.
    Echeverria I; Pereboev A; Silva L; Zabaleta A; Riezu-Boj JI; Bes M; Cubero M; Borras-Cuesta F; Lasarte JJ; Esteban JI; Prieto J; Sarobe P
    Hepatology; 2011 Jul; 54(1):28-37. PubMed ID: 21452282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus core and E1 proteins.
    Sarobe P; Lasarte JJ; Casares N; López-Díaz de Cerio A; Baixeras E; Labarga P; García N; Borrás-Cuesta F; Prieto J
    J Virol; 2002 May; 76(10):5062-70. PubMed ID: 11967322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of antigen-specific immune responses in vivo after vaccination with dendritic cells transduced with adenoviral vectors encoding hepatitis C virus NS3.
    Xiang M; Eisenbach C; Lupu CM; Ernst E; Stremmel W; Encke J
    Viral Immunol; 2006; 19(2):210-9. PubMed ID: 16817764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40.
    Zabaleta A; Arribillaga L; Llopiz D; Dotor J; Lasarte JJ; Prieto J; Borrás-Cuesta F; Esteban JI; Quer J; Vayreda F; Sarobe P
    Antiviral Res; 2007 Apr; 74(1):25-35. PubMed ID: 17275104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination against hepatitis C virus with dendritic cells transduced with an adenovirus encoding NS3 protein.
    Zabaleta A; Llopiz D; Arribillaga L; Silva L; Riezu-Boj JI; Lasarte JJ; Borrás-Cuesta F; Prieto J; Sarobe P
    Mol Ther; 2008 Jan; 16(1):210-7. PubMed ID: 17923840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteins.
    Satoi J; Murata K; Lechmann M; Manickan E; Zhang Z; Wedemeyer H; Rehermann B; Liang TJ
    J Virol; 2001 Dec; 75(24):12121-7. PubMed ID: 11711603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation.
    Dolganiuc A; Kodys K; Kopasz A; Marshall C; Do T; Romics L; Mandrekar P; Zapp M; Szabo G
    J Immunol; 2003 Jun; 170(11):5615-24. PubMed ID: 12759441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic and therapeutic vaccination with dendritic cells against hepatitis C virus infection.
    Encke J; Findeklee J; Geib J; Pfaff E; Stremmel W
    Clin Exp Immunol; 2005 Nov; 142(2):362-9. PubMed ID: 16232225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broadening CD4
    Filskov J; Mikkelsen M; Hansen PR; Christensen JP; Thomsen AR; Andersen P; Bukh J; Agger EM
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28446674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of cytotoxic T-cell response against hepatitis C virus structural antigens using a defective recombinant adenovirus.
    Bruña-Romero O; Lasarte JJ; Wilkinson G; Grace K; Clarke B; Borrás-Cuesta F; Prieto J
    Hepatology; 1997 Feb; 25(2):470-7. PubMed ID: 9021966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of cellular immune responses to HCV NS5 protein through in vivo activation of dendritic cells.
    Wintermeyer P; Gehring S; Eken A; Wands JR
    J Viral Hepat; 2010 Oct; 17(10):705-13. PubMed ID: 20002303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of hepatitis C virus-specific cytotoxic T and B cell responses by dendritic cells expressing a modified antigen targeting receptor.
    Wang QC; Feng ZH; Zhou YX; Nie QH
    World J Gastroenterol; 2005 Jan; 11(4):557-60. PubMed ID: 15641145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.
    Zeng R; Li G; Ling S; Zhang H; Yao Z; Xiu B; He F; Huang R; Wei L
    Antiviral Res; 2009 Oct; 84(1):23-30. PubMed ID: 19646486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monocyte-derived dendritic cells from HCV-infected patients transduced with an adenovirus expressing NS3 are functional when stimulated with the TLR3 ligand poly(I:C).
    Echeverría I; Zabaleta A; Silva L; Díaz-Valdés N; Riezu-Boj JI; Lasarte JJ; Borrás-Cuesta F; Civeira MP; Prieto J; Sarobe P
    J Viral Hepat; 2008 Nov; 15(11):782-9. PubMed ID: 18637068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic ethanol consumption impairs cellular immune responses against HCV NS5 protein due to dendritic cell dysfunction.
    Aloman C; Gehring S; Wintermeyer P; Kuzushita N; Wands JR
    Gastroenterology; 2007 Feb; 132(2):698-708. PubMed ID: 17258730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved dendritic cell-based immunization against hepatitis C virus using peptide inhibitors of interleukin 10.
    Díaz-Valdés N; Manterola L; Belsúe V; Riezu-Boj JI; Larrea E; Echeverria I; Llópiz D; López-Sagaseta J; Lerat H; Pawlotsky JM; Prieto J; Lasarte JJ; Borrás-Cuesta F; Sarobe P
    Hepatology; 2011 Jan; 53(1):23-31. PubMed ID: 21154952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus structural proteins do not prevent human dendritic cell maturation.
    Thumann C; Schvoerer E; Abraham JD; Bohbot A; Stoll-Keller F; Aubertin AM; Kieny MP
    Gastroenterol Clin Biol; 2008 Jan; 32(1 Pt. 1):59-68. PubMed ID: 18341978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization against hepatitis C virus with a fusion protein containing the extra domain A from fibronectin and the hepatitis C virus NS3 protein.
    Mansilla C; Gorraiz M; Martinez M; Casares N; Arribillaga L; Rudilla F; Echeverria I; Riezu-Boj JI; Sarobe P; Borrás-Cuesta F; Prieto J; Lasarte JJ
    J Hepatol; 2009 Sep; 51(3):520-7. PubMed ID: 19596480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA prime-canarypox boost with polycistronic hepatitis C virus (HCV) genes generates potent immune responses to HCV structural and nonstructural proteins.
    Pancholi P; Liu Q; Tricoche N; Zhang P; Perkus ME; Prince AM
    J Infect Dis; 2000 Jul; 182(1):18-27. PubMed ID: 10882577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.